Biotechnology and nanotechnology in Poland in 2023
A
A
A
In 2023, 195 firms conducted biotechnology activities, which constitutes an increase by 4.3% in comparison to the previous year. Biotechnology intramural expenditures incurred by firms amounted to PLN 2 382.2 million and increased by 22.0% on an annual basis. In 2023, 4 482 persons were employed in biotechnology in firms. Biotechnology research and experimental development was conducted by 239 entities, that is, by 2.1% more in comparison with the previous year. Biotechnology R&D intramural expenditures amounted to PLN 1 719.9 million and increased by 20.1% annually. 8 419 persons were involved in biotechnology research and experimental development.
83 firms conducted nanotechnology activities, i.e. by 18.6% more than in the previous year. Intramural expenditures on nanotechnology incurred by firms amounted to PLN 390.0 million and were lower by 19.7% in comparison with the previous year. 3 339 persons were employed in the field of nanotechnology, of which 1 264 persons in firms. Research and experimental development in the field of nanotechnology was carried out by 146 entities, by 16,8% more in comparison with the previous year. Nanotechnology R&D intramural expenditures amounted to PLN 380.3 million and were by 4.9% lower than in the previous year. 2 610 persons were involved in nanotechnology research and experimental development.
